Aurobindo Pharma Limited (NSE:AUROPHARMA)
1,235.50
-3.80 (-0.31%)
Nov 19, 2025, 11:05 AM IST
Revenue by Product
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Revenue by Geography
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.